Slides
Page 1
Q3 2026 RESULTS Earnings Call NASDAQ GLOBAL MARKET: CCLD A leading provider of technology-enabled services and AI-based solutions for the healthcare revenue cycle © CareCloud, Inc. 2026
Page 2
Q3 2026 EARNINGS CALL 01 FORWARD - LOOKING STATEMENTS Safe Harbor Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “pla ns,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” “approximately,” or “continue” or the negative of these terms or other similar terms and phrases. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward -looking statements ultimately prove to be correct. Forward-looking statements in this presentation include, without limitation, statements reflecting management's expecta tions for future financial performance and operating expenditures, expected growth, our ability to raise additional capital and to succeed in our future operations, profitability and business outlook, increased sales and marketing expenses, and the expecte d results from the integration of our acquisitions. MATERIAL RISK FACTORS — OUR ABILITY TO: • Maintain operations in Pakistan, Azad Jammu and Kashmir, and Sri Lanka in a manner that continues to enable us to offer competitively priced products and services; • Operate in a global business environment that may be affected by geopolitical developments, including regional conflicts, trade restrictions, sanctions, changes in diplomatic relations or political stability; • Consistently achieve and maintain compliance with a myriad of federal, state, foreign, local, payor and industry requirements, regulations, rules, laws and contracts; • Respond to the recent cybersecurity incident and effectively integrate, manage and keep our information systems secure and operational in the event of another cyber-attack; • Manage our growth, including acquiring, partnering with, and effectively integrating the acquisitions of Empower Healthcare & Compliance Partners, MAP App, Medsphere Systems Corporation, RevNu Medical Management and other acquired businesses into our infrastructure and avoiding legal exposure and liabilities associated with our acquisitions; • Retain our clients and revenue levels, including effectively migrating new clients and maintaining or growing the revenue levels of our new and existing clients; • Keep pace with a rapidly changing healthcare industry, including the use of artificial intelligence (“AI”); • Maintain and protect the privacy of confidential and protected Company, client and patient information; • Develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards and third-party software platforms and technologies, and protect and enforce all of these and other intellectual property rights; • Attract and retain key officers and employees, and the continued involvement of Mahmud Haq as Executive Chairman, Stephen Snyder as Chief Executive Officer and A. Hadi Chaudhry as Chief Strategy Officer, all of which are critical to our ongoing operations and growing our business; • Realize the expected cost savings and benefits from our restructuring activities and structural cost reductions; • Make assumptions regarding the continuation, signing, scope and timing of certain client, vendor and partner relationships and the commencement and timing of client projects, which reflect management’s current beliefs and expectations and may not materialize on the anticipated schedule or at all; • Timely and effectively complete the integration of acquired businesses and execute expense -structure and related operational initiatives necessary to align our cost structure with our adjusted EBITDA and earnings -per-share objectives; • Comply with the covenants and the required principal and interest payments contained in our credit agreement with our senior secured lenders, Citizens Bank, N.A. and Provident Bank, and other future debt facilities; • Continue to pay our monthly dividends to the holders of our Series A Preferred Stock; • Incorporate AI into our products faster and more successfully than our competitors, protecting the privacy of medical records and cybersecurity threats; • Compete with other companies developing products and selling services competitive with ours, and who may have greater resources and name recognition than we have; • Respond to the uncertainty resulting from pandemics, epidemics or other public health emergencies and the impact they may have on our operations, the demand for our services, our projected results of operations, financial performance or other financial metrics or any of the foregoing risks and economic activity in general; • Keep and increase market acceptance of our products and services; • Respond to changes in domestic and foreign business, market, financial, political and legal conditions; and • Other factors disclosed in our other filings with the Securities and Exchange Commission. Although we believe that the expectations reflected in the forward -looking statements contained in this presentation are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. In this presentation, we disclose certain non-GAAP historical and projected financial measures, including adjusted EBITDA. We be lieve that these non-GAAP financial measures provide useful information to both management and investors by excluding certain items and expenses that are not indicative of our core operating results or do not reflect our normal business operat ions. Our use of non-GAAP financial measures has certain limitations in that such non- GAAP financial measures may not be directly comparable to those reported by other companies. We seek to compensate for the limitation of our non- GAAP financial measures by providing a detailed reconciliation of the non- GAAP financial measures to the most directly comparable U.S. GAAP financial measures. Investors are encouraged to review the related U.S. GAAP financial measures and the reconciliation of these non- GAAP financial measures to their most directly comparable U.S. GAAP financial measures. The statements in this presentation are made as of the date of this presentation, and the Company does not assume any obligat ions to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. CARECLOUD, INC. NASDAQ: CCLD 01
Page 3
Q3 2026 EARNINGS CALL 02 HOSTS FOR Q3 2026 EARNINGS CALL Today's Speakers Mahmud Haq FOUNDER & EXECUTIVE CHAIRMAN Stephen Snyder CHIEF EXECUTIVE OFFICER Hadi Chaudhry CHIEF STRATEGY OFFICER Bonnie Boyer CHIEF FINANCIAL OFFICER CARECLOUD, INC. 02
Page 4
03 OPENING REMARKS · Q3 2026 Stephen Snyder — CHIEF EXECUTIVE OFFICER CARECLOUD, INC. 03
Page 5
REVENUE ($M) $31.1 $33.7 Q3'25 Q3'26 +8.6% YoY GAAP NET INCOME ($M) $3.1 $4.7 Q3'25 Q3'26 +54.5% YoY ADJ. EBITDA* ($M) $7.7 $9.9 Q3'25 Q3'26 +27.8% YoY GAAP EPS $0.04 $0.10 Q3'25 Q3'26 +150% YoY RECORD RECORD RECORD Q3 2026 EARNINGS CALL 04 Q3 2026 FINANCIAL HIGHLIGHTS Year-over-year performance CARECLOUD, INC. (*) NON -GAAP MEASURE — SEE APPENDIX 04
Page 6
Q3 2026 EARNINGS CALL 05 WHAT DROVE THE MARGIN What drove record profitability CARECLOUD, INC. 05 Three drivers behind the quarter's margin expansion 01 AI AND AUTOMATION 44% fewer manual claim touches in the last three months Automated claim validation, denial prediction and remittance processing let the same teams handle more volume. 02 DISCIPLINE Revenue +8.6% Op. expenses -2.5% operating expenses down while revenue grew Total operating expenses decreased 2.5% year over year on revenue growth of 8.6%. Operating leverage is doing what it is built to do. 03 MIX $24.3M technology-enabled business solutions revenue, up from $21.6M Deliberately growing higher-margin technology and compliance offerings and leaning away from lower- margin, project-based services. +8.6% Revenue $31.1M → $33.7M +27.8% Adjusted EBITDA* $7.7M → $9.9M +54.5% GAAP net income $3.1M → $4.7M * NON -GAAP MEASURE — SEE APPENDIX
Page 7
Q3 2026 EARNINGS CALL 06 CAPITAL STRUCTURE A two-year rebuild, now working for common shareholders CARECLOUD, INC. 06 DECREASE OF PREFERRED DIVIDEND OBLIGATION S OVER TIME JUNE 2024 Two series of preferred outstanding; Series A at 11% ~$16M / yr SEPTEMBER 2024 Series A holders approve rate cut to 8.75% ~$13M / yr MARCH 2025 About 80% of Series A converted to common ~$5.5M / yr MAY 2026 Series B fully redeemed ~$2.2M / yr NOW STAYS WITH COMMON SHAREHOLDERS ~$14M a year Preferred dividends are ~7x lower ~$16M a year to preferred in mid-2024, ~$2.2M today Remaining: ~985K shares of Series A at 8.75% per annum NET INCOME TO COMMON 89% of net income reached common shareholders this quarter, vs. about 55% a year ago. $4.2M to common, 2.5x the $1.7M of Q3 2025. DEBT TAKEN ON FOR THE REDEMPTION $41.6M Borrowed to retire Series B term loan + revolver, May 2026 $34.2M Term loan, Nov 2 $36.7M at Sep 30 · revolver fully repaid Incl. $833K extra payment, Nov 2 $7.4M Paid down in under six months net leverage 1.1x · $10M revolver undrawn
Page 8
Q3 2026 EARNINGS CALL 07 2026 OUTLOOK Full-year 2026 guidance reaffirmed CARECLOUD, INC. 07 REVENUE $128 – $132M 9M 2026 actual: $96.9M FY2025: $120.5M ADJUSTED EBITDA* $29 – $31M 9M 2026 actual: $21.2M FY2025: $27.5M · +5% to +13% GAAP EPS $0.20 – $0.23 9M 2026 actual: $0.09 FY2025: $0.10 · +100% to +130% FOURTH - QUARTER BUILDING BLOCKS · THE SAME ONES DESCRIBED IN AUGUST, NOW IN MOTION 1 Recurring revenue Continued growth in the recurring, technology-enabled base 2 Enterprise development AI platform work for enterprise clients, including LailaCare 3 Compliance launch Late-Q4 subscription offering; compliance across 40,000+ providers 4 Simpler capital structure Series B gone; term loan paid down monthly * NON- GAAP MEASURE — SEE APPENDIX. GUIDANCE DEPENDS ON THE SIGNING AND CONTINUATION OF CERTAIN CLIENT AND VENDOR RELATIONSHIPS, THE TIMING AND SCOPE OF CLIENT PROJECTS, AND EXECUTION OF INTEGRATION AND EXPENSE -MANAGEMENT INITIATIVES.
Page 9
08 AI & STRATEGY · Q3 2026 Hadi Chaudhry — CHIEF STRATEGY OFFICER CARECLOUD, INC. 08
Page 10
Q3 2026 EARNINGS CALL 09 AI & STRATEGY AI strategy: three tracks, measurable progress CARECLOUD, INC. 09 Executing on the three AI tracks we outlined earlier this year 01 AI INSIDE OUR OPERATIONS Doing our own work faster and more efficiently AI Center of Excellence advancing stratusAI products for internal use AI-assisted coding deployed in our coding services, expanding by specialty Automation and offshore delivery handling more volume 02 AI IN THE PRODUCTS CLIENTS USE Embedding AI into the platforms clients already run AI prior authorization live with a pilot client, connected to 105 payers New cirrusAI Notes companion app and expanded Breeze integration in Wellsoft Integrating the inpatient suite from Medsphere and MAP App 40,000+ Providers we can reach with AI- enabled offerings 03 NEW AI PLATFORMS Building AI-enabled platforms for enterprise clients KabaFusion: one of the nation's largest home infusion providers, serving patients in 49 states Selected CareCloud in August to build LailaCare, an AI platform for home infusion Designed and developed by CareCloud, owned by KabaFusion Q3 One platform from referral to payment; first revenue recognized in Q3 Next: stratusAI in Wellsoft (Q4) · Prior authorization into CareCloud Health · AI revenue reported separately once it reaches scale
Page 11
Q3 2026 EARNINGS CALL 10 AI & STRATEGY — AUTOMATION AI across the revenue cycle, from first call to final payment CARECLOUD, INC. 10 Where our AI works today, for clients and inside our own operations PATIENT ACCESS stratusAI Front Desk AI voice agent live with clients and in our own patient call center LIVE DOCUMENTATION cirrusAI Notes Ambient AI turning the visit into chart-ready documentation LIVE AUTHORIZATION AI prior authorization Live with a pilot client; connected to 105 payers, 75 for submission LIVE · EXPANDING CODING AI-assisted coding Deployed in our coding services, expanding specialty by specialty LIVE · EXPANDING CLAIMS & PAYMENT Back-office automation Automation and offshore delivery across RCM workflows INTERNAL INSIDE OUR OWN RCM OPERATIONS 84% Zero-touch processing in the division serving most RCM clients, up from 74% 44% Fewer manual claim touches in the same division, Aug–Oct 2026 52% Lower denial rate, from 8% to under 4% (Q3 YoY) AI PRIOR AUTHORIZATION, IN PRODUCTION 105 Payers connected; 75 accept electronic submission <2 min Submission time, down from 15 minutes 91% Initial-pass approval, 600+ submissions Internal, unaudited operating metrics reflecting AI, automation and process initiatives. Zero-touch (Nov 2025–Oct 2026) and manual touches (Aug–Oct 2026): division serving most of our RCM clients; denial rate: all RCM operations, Q3 2026 vs Q3 2025.
Page 12
Q3 2026 EARNINGS CALL 11 AI & STRATEGY — INPATIENT PLATFORM Medsphere: a modern, AI-ready inpatient platform CARECLOUD, INC. 11 Hospital and emergency-department technology acquired in August 2025 Q3 2026 REVENUE CONTRIBUTION $6.3M CareVue Inpatient EHR Wellsoft Emergency-department system Inpatient RCM Hospital revenue cycle MODERNIZATION MILESTONES Q1 –Q2 2026 Integration and platform parity Integration complete; inpatient RCM and CareVue parity delivered DONE Q2–Q3 2026 AI in the emergency department Breeze and cirrusAI Notes live in Wellsoft; both expanded in Q3 DONE Q3 2026 Security and compliance Wellsoft DEA audit certification testing and security hardening completed DONE Q4 2026 stratusAI in Wellsoft AI front-desk capabilities in the emergency-department workflow ON TRACK Q4 2026 Wellsoft as cloud SaaS Full cloud-based SaaS modernization ON TRACK 36 product releases in Q3 across Wellsoft, MAP App, Marketware and HealthLine · Long-term: one modular platform with a common data and AI foundation
Page 13
12 FINANCIAL REVIEW · Q3 2026 Bonnie Boyer — CHIEF FINANCIAL OFFICER CARECLOUD, INC. 12
Page 14
Q3 2026 EARNINGS CALL 13 FINANCIAL REVIEW Margins expanding: profit growing faster than revenue CARECLOUD, INC. 13* NON-GAAP MEASURE — SEE APPENDIX Q3 2026 vs. Q3 2025 Year-over-year growth Revenue $31.1M → $33.7M +8.6% Adjusted EBITDA* $7.7M → $9.9M +27.8% GAAP net income $3.1M → $4.7M +54.5% Margin expansion ADJUSTED EBITDA MARGIN* 24.9% → 29.3% +4.4 pts REVENUE LESS DIRECT OPERATING COSTS 47.8% → 50.5% +2.7 pts WHAT DROVE IT Higher-margin mix: growth in technology and compliance offerings, less lower- margin services More efficient core business: automation and offshore delivery handling more volume Disciplined operating costs: total operating expenses decreased 2.5% on revenue up 8.6% Q3 2025 Q3 2026 Q3 2025 Q3 2026
Page 15
Q3 2026 EARNINGS CALL 14 FINANCIAL REVIEW More of our earnings now go to common shareholders CARECLOUD, INC. 14* NON-GAAP MEASURE, SEE APPENDIX. Series B Preferred Stock redeemed May 15, 2026; Q3 2026 net income reflects $1.7M higher net interest expense, including $0.9M of non-cash warrant expense. GAAP net income split between preferred dividends and common shareholders ($M) $1.7 $1.4 Net income $3.1 Q3 2025 55% to common shareholders $4.2 $0.5 Net income $4.7 Q3 2026 89% to common shareholders To common shareholders Preferred dividends NET INCOME TO COMMON $4.2M Q3 2025: $1.7M (2.5x) USES OF FREE CASH FLOW $11.9M 9M free cash flow* 1 Pay down the term loan $36.7M at Sep 30, from $40.0M at closing (April 2026) 2 Selective, cash-funded tuck-in acquisitions
Page 16
Q3 2026 EARNINGS CALL 15 FINANCIAL REVIEW A simpler, deleveraging balance sheet CARECLOUD, INC. 15 Capitalization at September 30, 2026 Capitalization Common shares outstanding (Oct 31, 2026) 42.55M Cash $4.6M Term loans and other debt $37.3M Net debt $32.7M Series A preferred stock (liquidation preference) $24.6M Series B preferred stock Redeemed May 15, 2026 Trailing twelve-month adjusted EBITDA* $28.9M Net debt / adjusted EBITDA* 1.1x NET LEVERAGE 1.1x Net debt / trailing 12-month adjusted EBITDA* TERM LOAN PAYDOWN $3.3M Since April 2026 funding ($40.0M to $36.7M) PREFERRED DIVIDENDS $0.5M Q3 2026, down from $1.4M in Q3 2025 Key takeaway: Leverage is low at about 1.1x and declining as we pay down the term loan monthly from free cash flow, and our $10 million revolver is undrawn for flexibility. * NON-GAAP MEASURE, SEE APPENDIX. Trailing twelve months = Q4 2025 adjusted EBITDA of $7.7M (as previously reported) plus 9M 2026 of $21.2M. In compliance with all credit facility covenants at September 30, 2026.
Page 17
16 CLOSING REMARKS · Q3 2026 Mahmud Haq — FOUNDER & EXECUTIVE CHAIRMAN CARECLOUD, INC. 16
Page 18
Thank You! INVESTOR RELATIONS ir.carecloud.com CONTACT ir@carecloud.com WEB carecloud.com CARECLOUD, INC. 17
Page 19
NON - GAAP RECONCILIATIONS Appendix CARECLOUD, INC. 18
Page 20
Q3 2026 EARNINGS CALL A1 NON- GAAP RECONCILIATION GAAP Net Income to Adjusted EBITDA $ IN THOUSANDS Q3'25 Q3'26 GAAP net income $ 3,060 $ 4,727 Provision for income taxes 43 127 Net interest expense 52 1,720 Foreign exchange / other expense 60 7 Stock-based compensation expense 88 65 Depreciation and amortization 4,022 3,189 Transaction and integration costs 391 77 Restructuring costs 17 — Change in contingent consideration — (32) Adjusted EBITDA $ 7,733 $ 9,880 CARECLOUD, INC. APPENDIX 19 9M'25 9M'26 $ 7,910 $ 6,771 126 281 85 2,510 120 93 307 193 10,741 10,957 414 401 154 — — (9) $ 19,857 $ 21,197
Page 21
Q3 2026 EARNINGS CALL A2 NON- GAAP RECONCILIATION GAAP Net Income to Adjusted Net Income $ IN THOUSANDS Q3'25 Q3'26 GAAP net income $ 3,060 $ 4,727 Foreign exchange / other expense 60 7 Stock-based compensation expense 88 65 Amortization of purchased intangible assets 794 939 Transaction and integration costs 391 77 Restructuring costs 17 — Change in contingent consideration — (32) Income tax expense related to goodwill — 45 Adjusted Net Income $ 4,410 $ 5,828 CARECLOUD, INC. APPENDIX 20 9M'25 9M'26 $ 7,910 $ 6,771 120 93 307 193 1,076 2,812 414 401 154 — — (9) — 95 $ 9,981 $ 10,356
Page 22
Q3 2026 EARNINGS CALL A3 NON- GAAP RECONCILIATION Net Cash Provided by Operating Activities to Free Cash Flow $ IN THOUSANDS Q3'25 Q3'26 Net cash provided by operating activities $ 7,365 $ 5,643 Purchases of property and equipment (869) (328) Capitalized software & other intangible assets (828) (1,526) Free Cash Flow $ 5,668 $ 3,789 Net cash used in investing activities* $ (17,697) $ (2,140) Net cash (used in) provided by financing activities $ 4,920 $ (12,264) *Net cash used in investing activities includes payments for acquisitions, purchases of property and equipment and capitalized software and other intangible assets. Purchases of property and equipment and capitalized software and other intangible assets are included in our computation of free cash flow. CARECLOUD, INC. APPENDIX 21 9M'25 9M'26 $ 19,886 $ 16,327 (2,655) (1,265) (2,505) (3,146) $ 14,726 $ 11,916 $ (21,200) $ (5,378) $ 1,226 $ (9,940)